Shopping Cart
- Remove All
Your shopping cart is currently empty
MYCi975 (NUCC-0200975) is an orally active MYC inhibitor.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $127 | In Stock | |
| 5 mg | $297 | In Stock | |
| 10 mg | $492 | In Stock | |
| 25 mg | $819 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $383 | In Stock |
| Description | MYCi975 (NUCC-0200975) is an orally active MYC inhibitor. |
| In vitro | MYCi975 inhibits P493-6, MV411,SK-N-B2 cells viability in an MYC-dependent manner(IC50s of 3.7, 3.9, 6.4 μM, respectively)[1]. |
| In vivo | The initial lead, MYC inhibitor 361 (MYCi361), suppressed in vivo tumor growth in mice, increased tumor immune cell infiltration, upregulated PD-L1 on tumors, and sensitized tumors to anti-PD1 immunotherapy. However, 361 demonstrated a narrow therapeutic index. An improved analog, MYCi975 showed better tolerability. |
| Synonyms | NUCC-0200975 |
| Molecular Weight | 561.3 |
| Formula | C25H16Cl2F6N2O2 |
| Cas No. | 2289691-01-4 |
| Smiles | O(CC1=CC=C(Cl)C=C1)C2=C(C(O)=C(C=C2)C3=CC(C(F)(F)F)=NN3C)C4=CC(C(F)(F)F)=C(Cl)C=C4 |
| Relative Density. | 1.45 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 247 mg/mL (440.05 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.